Literature DB >> 14520598

Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain.

H L Müller1, M Heinrich, K Bueb, N Etavard-Gorris, U Gebhardt, R Kolb, N Sörensen.   

Abstract

The substitution of dexamethasone during and after surgery of childhood craniopharyngioma is necessary in order to treat and/or prevent brain edema and adrenal insufficiency. Early post-operative weight gain is a predictor for severe obesity during long-term follow-up. In a retrospective analysis of 60 patients with childhood craniopharyngioma we inquired whether dose and duration of perioperative dexamethasone therapy (n = 68) had influence on short-term post-operative weight gain and long-term development of severe obesity. The median follow-up period was 4.2 years, ranging from 1 to 9 years. 24 patients (14 f/10 m) developed severe obesity (BMI > 3 SD). 28 patients (10 f/18 m) retained normal weight (BMI < 2 SD). Eight patients presented with a BMI between 2 and 3 SD at the final visit. Differences in terms of age at surgery or follow-up period were non-detectable between the analyzed groups of craniopharyngioma patients. Duration and cumulative dexamethasone doses (mg/m2 BSA) for perioperative dexamethasone therapy were similar for severely obese patients (duration: 8.7 d; 4.5 - 17 d, cumulative dose: 74; 42 - 177 mg/m2 BSA) and normal weight patients (duration: 10.0 d; 1 - 41 d; dose: 76; 9 - 390 mg/m2 BSA). Whereas cumulative dexamethasone doses positively (p < 0.01; rho: 0.424) correlated with weight gain during the first year following surgery, long-term development of severe obesity was not influenced by dose and duration of perioperative dexamethasone treatment. Patients who developed severe obesity during follow-up had a higher (p < 0.001) BMI already at the time of diagnosis. We conclude that dose and duration of perioperative dexamethasone treatment had short-term effects on post-operative weight gain, but not on the development of long-term severe obesity. The results of our retrospective analysis are currently tested in a prospective surveillance study Kraniopharyngeom 2000 (www.kraniopharyngeom.com).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520598     DOI: 10.1055/s-2003-42722

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  19 in total

Review 1.  Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2010-09-28       Impact factor: 43.330

2.  Functional capacity and body mass index in patients with sellar masses--cross-sectional study on 403 patients diagnosed during childhood and adolescence.

Authors:  Hermann L Müller; Ursel Gebhardt; Andreas Faldum; Angela Emser; Nicole Etavard-Gorris; Reinhard Kolb; Niels Sörensen
Journal:  Childs Nerv Syst       Date:  2005-05-12       Impact factor: 1.475

Review 3.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 4.  Childhood craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

5.  Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma.

Authors:  Hermann L Müller; Gina Bruhnken; Angela Emser; Andreas Faldum; Nicole Etavard-Gorris; Ursel Gebhardt; Reinhard Kolb; Niels Sörensen
Journal:  Childs Nerv Syst       Date:  2005-06-18       Impact factor: 1.475

Review 6.  Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans.

Authors:  Michelle Lee; Judith Korner
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

7.  Preoperative BMI Predicts Postoperative Weight Gain in Adult-onset Craniopharyngioma.

Authors:  Daisy Duan; Leen Wehbeh; Debraj Mukherjee; Amir H Hamrahian; Fausto J Rodriguez; Sachin Gujar; Adham M Khalafallah; Camille Hage; Patrizio Caturegli; Gary L Gallia; Rexford S Ahima; Nisa M Maruthur; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

8.  Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience.

Authors:  Michal Cohen; Sharon Guger; Jill Hamilton
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-28       Impact factor: 5.555

Review 9.  Obesity and craniopharyngioma.

Authors:  Lorenzo Iughetti; Patrizia Bruzzi
Journal:  Ital J Pediatr       Date:  2011-08-16       Impact factor: 2.638

10.  Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma.

Authors:  Seung Wan Park; Hae Woon Jung; Young Ah Lee; Choong Ho Shin; Sei Won Yang; Jung-Eun Cheon; In-One Kim; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang
Journal:  J Neurooncol       Date:  2013-04-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.